NasdaqGS:WGSHealthcare
Surging AI-Driven Genetic Testing Demand Might Change The Case For Investing In GeneDx Holdings (WGS)
GeneDx Holdings recently reported very strong revenue growth of 51.90%, highlighting accelerating demand for its AI-powered genetic testing services focused on pediatric and rare disease diagnostics.
This expansion showcases how GeneDx’s use of AI in next-generation sequencing and clinical reporting is helping it build a differentiated position in genomics-focused healthcare.
Next, we’ll examine how this AI-driven genetic testing momentum shapes GeneDx Holdings’ investment narrative in light...